Biblio

Export 3136 results:
Author Title Type [ Year(Desc)]
2016
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
E. L. Goldwaser, Acharya, N. K., Sarkar, A., Godsey, G., and Nagele, R. G., Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer's Disease., J Alzheimers Dis, vol. 54, no. 2, pp. 445-56, 2016.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
R. E. Curiel, Crocco, E., Rosado, M., Duara, R., Greig, M. T., Raffo, A., and Loewenstein, D. A., A Brief Computerized Paired Associate Test for the Detection of Mild Cognitive Impairment in Community-Dwelling Older Adults., J Alzheimers Dis, vol. 54, no. 2, pp. 793-9, 2016.
L. De Beaumont, Pelleieux, S., Lamarre-Théroux, L., Dea, D., and Poirier, J., Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects., J Alzheimers Dis, vol. 54, no. 3, pp. 913-922, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
M. Mäkelä, Paetau, A., Polvikoski, T., Myllykangas, L., and Tanskanen, M., Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+)., J Alzheimers Dis, vol. 49, no. 1, pp. 149-57, 2016.
S. Chu, Xu, F., Su, Y., Chen, H., and Cheng, X., Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis., J Alzheimers Dis, vol. 51, no. 2, pp. 525-32, 2016.
K. Honda, Cerebral Arterial Occlusion Did Not Promote the Prevalence of Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 54, no. 1, pp. 269-74, 2016.
S. L. Gardener, Sohrabi, H. R., Shen, K. - K., Rainey-Smith, S. R., Weinborn, M., Bates, K. A., Shah, T., Foster, J. K., Lenzo, N., Salvado, O., Laske, C., Laws, S. M., Taddei, K., Verdile, G., and Martins, R. N., Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults., J Alzheimers Dis, vol. 52, no. 2, pp. 661-72, 2016.
S. Akoudad, M Gurol, E., Fotiadis, P., Koudstaal, P. J., Hofman, A., M Ikram, A., Greenberg, S. M., and Vernooij, M. W., Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study., J Alzheimers Dis, vol. 53, no. 2, pp. 497-503, 2016.
N. Wang, Allali, G., Kesavadas, C., Noone, M. L., Pradeep, V. G., Blumen, H. M., and Verghese, J., Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study., J Alzheimers Dis, vol. 50, no. 3, pp. 699-707, 2016.
B. - L. Ho, Kao, Y. - H., Chou, M. - C., and Yang, Y. - H., Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease., J Alzheimers Dis, vol. 54, no. 1, pp. 351-7, 2016.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W., Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort., J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
D. Renard, Gabelle, A., Hirtz, C., Demattei, C., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis., J Alzheimers Dis, vol. 54, no. 4, pp. 1291-1295, 2016.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M., Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I., Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents., J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
W. R. Shankle, Hara, J., Barrentine, L. W., and Curole, M. V., CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease., J Alzheimers Dis, vol. 54, no. 3, pp. 1073-1084, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
J. J. Armstrong, Godin, J., Launer, L. J., White, L. R., Mitnitski, A., Rockwood, K., and Andrew, M. K., Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study., J Alzheimers Dis, vol. 53, no. 3, pp. 1003-13, 2016.

Pages